Abstract:BackgroundCarbonic anhydrase VI (CA-VI) is produced by the salivary gland and is secreted into the saliva. Although CA-VI is found in the epithelial cells of distal straight tubule of swine kidneys, the exact function of CA-VI in the kidneys remains unclear.ResultsCA-VI was located in the epithelial cells of distal straight tubule of swine kidneys.A full-length cDNA clone of CA-VI was generated from the swine parotid gland by reverse transcription polymerase chain reaction, using degenerate primers designed ba… Show more
“…51 It is also produced in the nasal gland 52 and the kidney. 53 It was reported that urinary CAH6 might represent a biomarker for kidney disease in pigs, particularly for disorders affecting distal straight tubules. 54 Its role following ESWT administration is not clear.…”
Section: Discussionmentioning
confidence: 99%
“…This enzyme is abundantly found in salivary glands, and saliva has been implicated in taste and gastrointestinal dysfunctions, tooth erosion, and caries 51 . It is also produced in the nasal gland 52 and the kidney 53 . It was reported that urinary CAH6 might represent a biomarker for kidney disease in pigs, particularly for disorders affecting distal straight tubules 54 .…”
Extracorporeal shockwave therapy (ESWT) is a treatment applied to musculoskeletal injuries in equine athletes to alleviate pain and accelerate healing. ESWT also causes acute tissue damage. Therefore, its ability to act as an analgesic and cause tissue damage potentially increases the risk of a catastrophic event if used shortly before a strenuous competition such as horseracing. While ESWT is prohibited by many racing jurisdictions within 10 days prior to competition, a test to detect whether a horse has received ESWT is needed. ESWT changes the protein levels of inflammatory mediators in blood, and white blood cells (WBC) typically produce these proteins. Changes in gene expression precede changes in protein production; thus, it was hypothesized that WBC gene transcripts might serve as biomarkers of ESWT. To test this hypothesis, six thoroughbred horses received a single administration of ESWT to the distal limb, and WBC RNA was extracted from blood samples collected before (0 h) and after ESWT (2, 4, 6, 24, 48, and 72 h). Targeted and untargeted analyses evaluated the transcriptome using quantitative PCR (qPCR) and microarray. The expression of IL‐1α, IL‐1β, TNF‐α, IL‐1Ra1, IL‐1Ra2 and TGF‐β1, and BMPR1A in circulating WBCs was significantly up‐regulated, while IFN‐γ, ZNF483, TMEM80, CAH6, ENPP, and S8723 were significantly down‐regulated at various time points following ESWT. These data support the hypothesis that changes in WBC gene transcripts could serve as biomarkers for ESWT.
“…51 It is also produced in the nasal gland 52 and the kidney. 53 It was reported that urinary CAH6 might represent a biomarker for kidney disease in pigs, particularly for disorders affecting distal straight tubules. 54 Its role following ESWT administration is not clear.…”
Section: Discussionmentioning
confidence: 99%
“…This enzyme is abundantly found in salivary glands, and saliva has been implicated in taste and gastrointestinal dysfunctions, tooth erosion, and caries 51 . It is also produced in the nasal gland 52 and the kidney 53 . It was reported that urinary CAH6 might represent a biomarker for kidney disease in pigs, particularly for disorders affecting distal straight tubules 54 .…”
Extracorporeal shockwave therapy (ESWT) is a treatment applied to musculoskeletal injuries in equine athletes to alleviate pain and accelerate healing. ESWT also causes acute tissue damage. Therefore, its ability to act as an analgesic and cause tissue damage potentially increases the risk of a catastrophic event if used shortly before a strenuous competition such as horseracing. While ESWT is prohibited by many racing jurisdictions within 10 days prior to competition, a test to detect whether a horse has received ESWT is needed. ESWT changes the protein levels of inflammatory mediators in blood, and white blood cells (WBC) typically produce these proteins. Changes in gene expression precede changes in protein production; thus, it was hypothesized that WBC gene transcripts might serve as biomarkers of ESWT. To test this hypothesis, six thoroughbred horses received a single administration of ESWT to the distal limb, and WBC RNA was extracted from blood samples collected before (0 h) and after ESWT (2, 4, 6, 24, 48, and 72 h). Targeted and untargeted analyses evaluated the transcriptome using quantitative PCR (qPCR) and microarray. The expression of IL‐1α, IL‐1β, TNF‐α, IL‐1Ra1, IL‐1Ra2 and TGF‐β1, and BMPR1A in circulating WBCs was significantly up‐regulated, while IFN‐γ, ZNF483, TMEM80, CAH6, ENPP, and S8723 were significantly down‐regulated at various time points following ESWT. These data support the hypothesis that changes in WBC gene transcripts could serve as biomarkers for ESWT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.